@article {Dlamini:2018:2220-8372:S3,
title = "Case management of malaria in Swaziland, 20112015: on track for elimination?",
journal = "Public Health Action",
parent_itemid = "infobike://iuatld/pha",
publishercode ="iuatld",
year = "2018",
volume = "8",
number = "1",
publication date ="2018-04-25T00:00:00",
pages = "S3-S7",
itemtype = "ARTICLE",
issn = "2220-8372",
eissn = "2220-8372",
url = "https://www.ingentaconnect.com/content/iuatld/pha/2018/00000008/a00101s1/art00003",
doi = "doi:10.5588/pha.17.0047",
keyword = "Swaziland, SORT IT, malaria elimination, malaria case management",
author = "Dlamini, S. V. and Kosgei, R. J. and Mkhonta, N. and Zulu, Z. and Makadzange, K. and Zhou, S. and Owiti, P. and Sikhondze, W. and Namboze, J. and Reid, A. and Kunene, S.",
abstract = "
Objective: To assess adherence to malaria diagnosis and treatment guidelines (2010 and 2014) in all health care facilities in Swaziland between 2011 and 2015.
Methods: This was a cross-sectional descriptive study involving all health care facilities that diagnosed and
managed malaria cases in Swaziland. Patients' age, sex, diagnosis method and type of treatment were analysed.
Results: Of 1981 records for severe and uncomplicated malaria analysed, 56% of cases were uncomplicated and 14% had severe malaria. The type of malaria was not recorded for
30% of cases. Approximately 71% of cases were confirmed by rapid diagnostic tests (RDT) alone, 3% by microscopy alone and 26% by both RDT and microscopy. Of the uncomplicated cases, 93% were treated with artemether-lumefantrine (AL) alone, 5% with quinine alone and 2% with AL and quinine.
Amongst the severe cases, 11% were treated with AL alone, 44% with quinine alone and 45% with AL and quinine. For severe malaria, clinics and health centres prescribed AL alone more often than hospitals (respectively 13%, 12% and 4%, P = 0.03).
Conclusion: RDTs and/or microscopy
results are used at all facilities to inform treatment. Poor recording of malaria type causes difficulties in assessing the prescription of antimalarial drugs.",
}